繁體
简体中文
繁體中文

NexPoint Real Estate Finance NREF

已收盤 07-18 16:00:00 美东时间

13.90

-0.140

-1.00%

华盛通華盛通
立即下載
  • 最 高14.208
  • 今 開14.13
  • 成交量 4.35万股
  • 最 低 13.88
  • 昨 收 14.04
  • 總市值 2.46亿
  • 52周最高 16.5899
  • 市盈率 13.67
  • 換手率 0.00%
  • 52周最低 11.41
  • 委 比 0.00%
  • 總股本 1771.40万
  • 歷史最高 18.74
  • 量 比 1.05
  • 振 幅 2.34%
  • 歷史最低 -4.5498
  • 每 手 1
  • 風險率 0.95%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • NexPoint Real Estate Finance, Inc. Announces Series A Preferred Stock Dividend

    DALLAS, Texas, June 5, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE: NREF) (the "Company") today announced a dividend for its 8.50% Series A Cumulative Redeemable Preferred ...

    06-06 06:00

  • NexPoint Real Estate Finance Holds Annual Meeting

    NexPoint Real Estate ate Finance ( ($NREF) ) has issued an update. On May 20, 2...

    05-21 04:56

  • NexPoint projects Q2 2025 earnings distribution at $0.43-$0.48 per share

    Earnings Call Insights: NexPoint Real Estate Finance (NREF) Q1 2025 Management View Paul Richards, Executive Vice President and CFO, highlighted a turnaround in Q1 2025, reporting net income of $0.70 ...

    05-02 12:50

  • Earnings Scheduled For May 1, 2025

    Companies Reporting Before The Bell • Itron (NASDAQ:ITRI) is projected to repo...

    05-01 16:33

  • NexPoint Real Estate Finance, Inc. Announces Quarterly Dividend

    DALLAS, April 29, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) announced today that its board of directors has declared a quarterly regular ...

    04-30 04:30

  • 美股大行评级 | 潜在涨幅102.31%!瑞穗上调Amylyx制药目标价至7美元,评级升至"跑赢大市"

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116286800185102336.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 瑞穗:上调Amylyx Pharmaceuticals(AMLX)评级至"跑赢大市",目标价从3美元升至7美元</p> <p>• Redburn Atlantic:上调Roku(ROKU)评级至"买入",目标价100美元<

    04-08 10:08

  • 美股大行评级 | 美银证券:维持艾伯维"中性"评级,目标价从200美元升至223美元

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1103964892578983937.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通:维持Syndax制药(SNDX)"超配"评级,目标价从35美元升至39美元</p> <p>• 摩根大通:维持Apellis Pharmaceuticals(APLS)"超配"评级,目标价从50美元升至54美元</

    03-05 09:55

  • 美股大行评级 | Piper Sandler:上调ACNB Corp评级至"超配",目标价从37美元升至50美元

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1103601922058588161.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 丰业银行:维持Rocket Pharmaceuticals(RCKT)"跑赢大市"评级,目标价从51美元升至52美元</p> <p>• HC Wainwright &amp; Co.:维持Revolution Medici

    03-04 08:54

  • NexPoint Real Estate Finance, Inc. Announces Quarterly Dividend

    DALLAS, Feb. 26, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) announced today that its board of directors has declared a quarterly regular d...

    02-27 07:00

  • NexPoint Real Estate Finance Q4 2024 Earnings Preview

    NexPoint Real Estate Finance (NYSE:NREF) is scheduled to announce Q4 earnings results on Thursday, February 27th, before market open. The consensus EPS Estimate is $0.76 and the consensus Revenue Esti...

    02-27 03:25